Rate My Professor Eva Segelov
Ratings & reviews
A true mentor who cares about success.
A true expert who inspires confidence.
Encourages students to think independently.
Creates a welcoming and inclusive environment.
Encourages innovative and creative solutions.
Taught by or worked with Eva?
Add your rating. It takes about 30 seconds.
About Eva
Professor Eva Segelov, MBBS (Hons 1), PhD, FRACP, is a medical oncologist recognised internationally for her expertise in gastrointestinal cancers, including neuroendocrine tumours, breast cancer, clinical trials, and translational research. She graduated in medicine from the University of Sydney in 1988, completed her PhD there in 1998, and became a Fellow of the Royal Australasian College of Physicians in Medical Oncology in 1994. Her early career included roles as NHMRC Research Fellow at Westmead Hospital and Locum Staff Specialist at Liverpool Hospital. From 1998 to 2004, she served as Senior Lecturer in Medicine at the South Western Sydney Clinical School, University of New South Wales (UNSW), Director of Medical Student Education, Consultant Medical Oncologist at Liverpool Hospital, and Head of Cancer Research Laboratories. She advanced to Associate Professor of Medicine at St Vincent’s Clinical School, UNSW (2004-2016), Senior Specialist in Medical Oncology at St Vincent’s Hospital and Private Hospital, and Director of Conjoint Liaison and Medical Student Education at UNSW Faculty of Medicine.
In February 2017, Professor Segelov was appointed Professor of Oncology in the Department of Medicine and Director of Oncology at Monash University and Monash Health, roles she held until August 2022. She chaired the Cancer and Blood Theme at Monash Partners Comprehensive Cancer Consortium, acted as Director of Southern Melbourne Integrated Cancer Services (2017-2018), and headed the Oncology Translational Laboratory at the School of Clinical Sciences, Monash University. She led multiple investigator-initiated clinical trials, including Principal Investigator of the ICECREAM Phase II study, Co-Chair of the ASCOLT Phase III trial and its translational committee, Australian PI for QUASAR2 and SCOT Phase III trials, and Senior Australian PI for InterACCT. Her research emphasises translational studies of targeted therapies in subpopulations, new anticancer therapies, and therapy-induced molecular changes. Professor Segelov has authored over 150 articles, reviews, and book chapters, edited Advances in the Molecular Understanding of Colorectal Cancer, and contributed chapters such as Current Utility and Future Applications of ctDNA in Colorectal Cancer and Endoscopic Ultrasound in Pancreatic Cancer. Awards include the John Zalcberg Award for Excellence in AGITG Research (2022), AGITG Best New Concept Award (2016), UNSW Vice-Chancellor’s Award for Teaching Excellence (2006), and Certificate of Outstanding Service from COSA (2010). She held leadership positions as Board Member of AGITG, Gastrointestinal Chair of COSA, Co-Founder of CommNETs, ESMO Faculty Member for Gastrointestinal, CUP, Endocrine Tumours and Others, and Associate Editor of Journal of Global Oncology. Since December 2022, she is Full Professor and Director of the Department of Clinical Research, Faculty of Medicine, University of Bern, and University Cancer Centre Inselspital, with adjunct Professor status at Monash University.
Trending Medicine Research & Publication News
Cell Press Bribery Investigation: Cancer Cell Editor Accused
Photo by Markus Winkler on Unsplash
AI-Powered Systematic Review Reproducibility | AcademicJobs
Photo by Igor Omilaev on Unsplash
Retraction Watch Hits 50,000 Retractions | AcademicJobs
Photo by Dmytro Yarish on Unsplash
ICMJE Authorship and AI Disclosure: 2025 Update
Photo by Markus Winkler on Unsplash
Image Manipulation Detection Adoption Rising | AcademicJobs
Photo by Michael Shtern on Unsplash
ClinicalTrials.gov Reporting Crackdown | AcademicJobs
Photo by National Cancer Institute on Unsplash